bioAffinity Technologies Inc. Warrant
Save
1.71M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Diagnostics & Research
Industry

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Similar securities

Based on sector and market capitalization

Report issue